Skip to content

To compare which drug works better in treatment of plaque psoriasis between 2 percent crisaborole cream vs 0.1 percent betamethasone valereate ointment.

A comparative study on the efficacy of topical 2 percent CRISABOROLE Cream vs 0.1 percent BETAMETHASONE VALEREATE Ointment in the treatment of Plaque Psoriasis-A Non Blinded Randomised Control Study. - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/08/072562
Enrollment
70
Registered
2024-08-16
Start date
Unknown
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L400- Psoriasis vulgaris

Interventions

Intervention1: 2 Percent Crisaborole Cream: 2 Percent Crisaborole Cream is applied over the lesion twice daily for 4 weeks ,once daily for next 4 weeks Control Intervention1: 0.1 percent Betamethasone

Sponsors

GURUPRAKASH A V
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patient clinically diagnosed as Psoriasis vulgaris with less than 10 percent Body Surface Area involvement. 2.Age above 12 years 3. Patient willing for consent , study and follow up. 4. Patient willing to take clinical photos. 5. Patient not on any other treatment with topical and systemic drugs for Psoriasis for at least past 1 month.

Exclusion criteria

Exclusion criteria: 1.Patients below 12 years. 2.Patients with Psoriasis involving more than 10 percent Body Surface Area. 3.Patients with Severe Psoriasis Vulgaris and Erythrodermic Psoriasis, Pustular Psoriasis, Guttate Psoriasis, Nail Psoriasis, Psoriatic Arthritis. 4.Patients who are on treatment with topical or systemic drugs specific to Psoriasis within past 1 month. 5.Patients with active infection at the study site. 6.Patient not willing for regular follow-up or to take clinical pictures. 7.Lactating or Pregnant women.

Design outcomes

Primary

MeasureTime frame
Resolution of psoriatic plaque assessed by PASI score Timepoint: Every week

Secondary

MeasureTime frame
Remission of the Psoriatic PlaqueTimepoint: 12 WEEKS

Countries

India

Contacts

Public ContactDr Guruprakash A V

Government Stanley Medical College and Hospital

dermanandan@gmail.com9841043213

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026